Month: June 2022
-
Cancer Nutrition Therapy Biotech Raises $47M in Early Funds
A start-up company developing nutritional therapies to attack precise molecular cancer targets is raising $47 million in its first venture funding round.
-
Preclinical 3-D Printed Breast Tissue Implant Study Begins
A study is underway testing 3-D printed regenerative breast tissue models, derived from genetically engineered plant cells, implanted in pigs.
-
AI Image Analysis Shown to Predict Embryo Health
An algorithm designed to analyze microscopic images is shown to largely predict the genetic integrity of embryos from in-vitro fertilization.
-
Diagnostics Companies Partner on Monkeypox Test
Two developers of tests for infectious diseases are collaborating on a molecular test to detect monkeypox, an emerging international public health concern.
-
Infographic – Q1 Mental Health Tech Funds Drop
After a year of nearly constant gains in 2021, venture investments in digital mental health companies took a sharp drop in the first quarter of 2022.
-
FDA Issues Action Plan for Rare Neuro Diseases
The Food and Drug Administration published its blueprint to encourage new treatments for rare neurodegenerative disorders, including ALS.
-
An Ultimate Guide to Engineering Consulting Firms
We shall discuss the benefits of using the services of experienced engineering consultants in this article.
-
Trial Underway of Nasal Spray Flu Vaccine
A clinical trial has begun testing an influenza vaccine given as a nasal spray with a conventional syringe-delivered vaccine among older U.S. adults.
-
Biotech in $1.5B Gene-Editing Tech License Deal
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease.
-
Gene Therapy Start-Up Gains $38M in Early Funds
A new company developing genetic treatments with a high-capacity engineered virus to deliver its therapeutic payloads is raising $38 million in venture funds.